In summary, this study revealed the first instance of the epigenetic regulator ASH2L participating in high glucose-induced fibrosis and inflammation through transcriptional activation of HIPK2, suggesting that there is potential for attenuate the progression of DN. Here, ASH2L is linked to liver dysplastic nodule.